VIVIMEDLAB Intraday Analysis...


Open 107.20 Change Price %
High 112.80 1 Day 2.80 2.63
Low 105.05 1 Week 11.10 11.29
Close 109.40 1 Month 13.70 14.32
Volume 2108883 1 Year 28.96 36.00
52 Week High 121.20
52 Week Low 68.00
VIVIMEDLAB Important Levels
Resistance 2 116.58
Resistance 1 113.62
Pivot 109.08
Support 1 105.18
Support 2 102.22
NSE INDIA Most Active Stocks
JPASSOCIAT 15.05 0.67%
GMRINFRA 15.45 7.67%
JINDALSTEL 100.15 7.69%
MARKSANS 48.60 20.00%
UNITECH 5.95 0.85%
RCOM 34.65 4.52%
IDEA 108.45 2.41%
FEDERALBNK 85.95 3.06%
SOUTHBANK 20.70 3.50%
JPPOWER 6.15 4.24%
NSE INDIA Top Gainers Stocks
MARKSANS 48.60 20.00%
GOLDTECH 9.75 19.63%
PANACEABIO 158.35 19.33%
AUSTRAL 0.35 16.67%
IL&FSENGG 64.10 16.33%
DHARSUGAR 34.90 15.75%
UMANGDAIRY 84.45 14.59%
KAMATHOTEL 39.45 10.66%
VISASTEEL 22.45 10.59%
PEARLPOLY 30.45 10.53%
NSE INDIA Top Losers Stocks
KSERASERA 0.10 -33.33%
VKSPL 0.10 -33.33%
HOTELRUGBY 4.00 -18.37%
LLOYDELENG 273.20 -16.59%
FCSSOFT 0.30 -14.29%
BLUECHIP 0.35 -12.50%
SRGINFOTEC 0.35 -12.50%
XLENERGY 2.85 -9.52%
ADHUNIK 7.85 -8.72%
GUJNREDVR 2.10 -8.70%

Vivimed Labs Limited (NSE: VIVIMEDLAB)

VIVIMEDLAB Technical Analysis 4
As on 20th Feb 2017 VIVIMEDLAB Share Price closed @ 109.40 and we RECOMMEND Buy for LONG-TERM with Stoploss of 87.80 & Strong Buy for SHORT-TERM with Stoploss of 94.84 we also expect STOCK to react on Following IMPORTANT LEVELS.
VIVIMEDLAB Target for February
1st Target up-side 102.06
2nd Target up-side 108.77
3rd Target up-side 115.47
1st Target down-side 82.94
2nd Target down-side 76.23
3rd Target down-side 69.53
VIVIMEDLAB Synopsis Technicals View
50 Day EMA N/A (Short Term)
100 Day EMA N/A (Mid Term) N/A
200 Day EMA N/A (Long Term) N/A
MACD (12 26 9) N/A N/A
RSI (14) N/A N/A
MFI (14) N/A N/A
CCI (20) N/A N/A
ADX (14) N/A N/A
10 Day Avg Volume N/A
VIVIMEDLAB Other Details
Segment EQ
Market Capital 0.00
Sector Services
Industry Business Services
Offical website
Veeranag Towers
2nd Floor
Hyderabad, 500007
Phone: 91 40 2717 6005
Fax: 91 40 2717 2242
Vivimed Labs Ltd announces closure of Trading Window   Equity Bulls   - 05th Feb 15
Vivimed Labs: Outcome of board meeting   - 14th Aug 14
Kitara Capital To Hike Stake In Vivimed Labs   DealCurry   - 07th Aug 14
Vivimed Labs Ltd to allot 20 lakh warrants on preferential basis at Rs. 315   Equity Bulls   - 06th Aug 14
Kitara Capital raising stake in Vivimed Labs   VC Circle   - 05th Aug 14
Sebi slaps Rs 10 lakh fine on Vivimed Labs for violation   Economic Times   - 24th Jul 14
Vivimed Labs buys Actavis Pharma unit   Hindu Business Line   - 01st Aug 13
Jacob Ballas picks 13.1% stake in Vivimed Labs on conversion of preference ...   VC Circle   - 22nd Mar 13
Vivimed Labs to acquire Finoso Pharma   Business Standard   - 14th Feb 13
Vivimed Labs gets Rs. 127-cr PE funding   Hindu Business Line   - 28th Sep 11
Interactive Technical Analysis Chart Vivimed Labs Limited ( VIVIMEDLAB NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from
Your Comments and Response on Vivimed Labs Limited
VIVIMEDLAB Business Profile
Vivimed Labs Limited, together with its subsidiaries, manufactures and sells specialty chemicals and pharmaceutical products in India and internationally. It operates through two segments, Speciality Chemicals and Pharmaceuticals. The company manufactures active ingredients, which are used in home and personal care segments, such as hair, skin, oral care, and anti-microbial preservatives, as well as used in industrial care segments comprising photo chromic dyes and imaging chemicals. Its products include antibacterials for toothpaste and mouthwash, and neutraceuticals for dental enamel protection in the oralcare market; UV filters for sun care products; skin care ingredients, such as active anti-wrinkle, anti-ageing compounds, anti-oxidants, skin-lightening actives, and emollients for use in skin care products; hair dye intermediates, anti-dandruff actives, and thickeners and conditioners for use in hair care products. The company also provides photochromic dyes for applications in plastics, films, coatings, and inks; anti-microbial actives for use in a range of applications from plastics additives to anti-bacterial hand washes; preservatives for various formulations; and photographic chemicals for use in the medical and industrial X-ray imaging, consumer photography, and litho-plate production for the graphic arts industry. In addition, it offers nutraceuticals for women and children, enzyme preparations, beta-lactams, heamatinics, anti-oxidants, cough expectorants, and multi-vitamins, as well as provides drugs for curing oncology space, arthritis, syndrome X, macular degeneration, psoriasis, and stress. Further, the company manufactures and markets active pharmaceutical ingredients and finished dosage formulations, which covers therapeutic segments, as well as provides contract manufacturing services and manufactures branded formulations. Vivimed Labs Limited was founded in 1988 and is headquartered in Hyderabad, India.